Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Dexamethasone intratympanic - Otonomy

Drug Profile

Dexamethasone intratympanic - Otonomy

Alternative Names: OTIVIDEX; OTO-104; Sustained release dexamethasone

Latest Information Update: 27 Jul 2018

Price : $50 *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Otonomy; University of California System
  • Developer Otonomy
  • Class Anti-inflammatories; Antiemetics; Antineoplastics; Fluorinated steroids; Glucocorticoids; Pregnadienetriols; Small molecules
  • Mechanism of Action Glucocorticoid receptor agonists; Immunosuppressants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • Phase III Meniere's disease
  • Phase II Sensorineural hearing loss

Most Recent Events

  • 26 Jul 2018 Otonomy initiates a pivotal phase III trial for Meniere's disease in Europe (Intratympanic)
  • 26 Jul 2018 Otonomy plans to recruit patients for a phase III trial for Meniere's disease in The Europe
  • 08 Mar 2018 Otonomy plans a pivotal trial for Meniere's disease in mid-2018
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top